Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
SEK 14.55
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Promimic AB (publ) manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets. It offers HAnano surface technology that combines various properties that are known to improve osseointegration into one unique surface modification. The company was incorporated in 2004 and is headquartered in Mölndal, Sweden.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Data is available to registered users only
Buy
Sell